EP1625104A2 - METHOD FOR PRODUCING CHIRAL alpha HYDROXYCARBOXYLIC CRYSTALLINE ACIDS - Google Patents
METHOD FOR PRODUCING CHIRAL alpha HYDROXYCARBOXYLIC CRYSTALLINE ACIDSInfo
- Publication number
- EP1625104A2 EP1625104A2 EP04706636A EP04706636A EP1625104A2 EP 1625104 A2 EP1625104 A2 EP 1625104A2 EP 04706636 A EP04706636 A EP 04706636A EP 04706636 A EP04706636 A EP 04706636A EP 1625104 A2 EP1625104 A2 EP 1625104A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- cells
- hours
- dmso
- reaction
- hydrolysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002253 acid Substances 0.000 title claims abstract description 21
- 150000007513 acids Chemical class 0.000 title claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 title abstract description 6
- 241000187561 Rhodococcus erythropolis Species 0.000 claims abstract description 18
- 230000007071 enzymatic hydrolysis Effects 0.000 claims abstract description 11
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims abstract description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 79
- 238000006243 chemical reaction Methods 0.000 claims description 71
- 210000004027 cell Anatomy 0.000 claims description 63
- 102000004190 Enzymes Human genes 0.000 claims description 31
- 108090000790 Enzymes Proteins 0.000 claims description 31
- 230000007062 hydrolysis Effects 0.000 claims description 23
- 238000006460 hydrolysis reaction Methods 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 22
- 239000006184 cosolvent Substances 0.000 claims description 20
- 230000000284 resting effect Effects 0.000 claims description 18
- -1 heteroaromatic aldehydes Chemical class 0.000 claims description 14
- 244000005700 microbiome Species 0.000 claims description 9
- 150000002576 ketones Chemical class 0.000 claims description 8
- 239000013612 plasmid Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 230000014509 gene expression Effects 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- 239000012736 aqueous medium Substances 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 3
- 239000007858 starting material Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 108010093096 Immobilized Enzymes Proteins 0.000 claims description 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 210000001822 immobilized cell Anatomy 0.000 claims description 2
- 239000003444 phase transfer catalyst Substances 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical group N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 abstract 1
- 239000000758 substrate Substances 0.000 description 48
- 239000000047 product Substances 0.000 description 30
- 239000000243 solution Substances 0.000 description 30
- ZECLJEYAWRQVIB-QMMMGPOBSA-N (2r)-2-(2-chlorophenyl)-2-hydroxyacetonitrile Chemical compound N#C[C@H](O)C1=CC=CC=C1Cl ZECLJEYAWRQVIB-QMMMGPOBSA-N 0.000 description 28
- 150000001261 hydroxy acids Chemical class 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 239000000872 buffer Substances 0.000 description 23
- 238000002474 experimental method Methods 0.000 description 22
- 239000002609 medium Substances 0.000 description 20
- 239000006285 cell suspension Substances 0.000 description 19
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 108010024026 Nitrile hydratase Proteins 0.000 description 17
- 230000000875 corresponding effect Effects 0.000 description 17
- 238000000855 fermentation Methods 0.000 description 17
- 230000004151 fermentation Effects 0.000 description 17
- 239000011942 biocatalyst Substances 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 108700023418 Amidases Proteins 0.000 description 12
- 102000005922 amidase Human genes 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 12
- 150000001408 amides Chemical class 0.000 description 11
- ZXKINMCYCKHYFR-UHFFFAOYSA-N aminooxidanide Chemical compound [O-]N ZXKINMCYCKHYFR-UHFFFAOYSA-N 0.000 description 11
- 238000005119 centrifugation Methods 0.000 description 11
- RWOLDZZTBNYTMS-SSDOTTSWSA-N (2r)-2-(2-chlorophenyl)-2-hydroxyacetic acid Chemical compound OC(=O)[C@H](O)C1=CC=CC=C1Cl RWOLDZZTBNYTMS-SSDOTTSWSA-N 0.000 description 10
- 239000006166 lysate Substances 0.000 description 10
- 150000001299 aldehydes Chemical class 0.000 description 9
- 238000006911 enzymatic reaction Methods 0.000 description 8
- 238000003306 harvesting Methods 0.000 description 8
- 150000002825 nitriles Chemical group 0.000 description 8
- 239000008363 phosphate buffer Substances 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 7
- 229960000723 ampicillin Drugs 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 239000002028 Biomass Substances 0.000 description 6
- 230000007306 turnover Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- CUJUQPVHWIDESZ-UHFFFAOYSA-N 2-hydroxy-4-phenylbutanenitrile Chemical compound N#CC(O)CCC1=CC=CC=C1 CUJUQPVHWIDESZ-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- BPHPUYQFMNQIOC-MBOVONDJSA-N (2r,3r,4s,5r)-2-(hydroxymethyl)-6-propan-2-ylsulfanyloxane-3,4,5-triol Chemical compound CC(C)SC1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-MBOVONDJSA-N 0.000 description 4
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000006340 racemization Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- NNICRUQPODTGRU-QMMMGPOBSA-N (R)-mandelonitrile Chemical compound N#C[C@H](O)C1=CC=CC=C1 NNICRUQPODTGRU-QMMMGPOBSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241001522878 Escherichia coli B Species 0.000 description 2
- 241001138401 Kluyveromyces lactis Species 0.000 description 2
- 241000235058 Komagataella pastoris Species 0.000 description 2
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 230000002210 biocatalytic effect Effects 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- OLNJUISKUQQNIM-UHFFFAOYSA-N indole-3-carbaldehyde Chemical compound C1=CC=C2C(C=O)=CNC2=C1 OLNJUISKUQQNIM-UHFFFAOYSA-N 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- NNICRUQPODTGRU-UHFFFAOYSA-N mandelonitrile Chemical compound N#CC(O)C1=CC=CC=C1 NNICRUQPODTGRU-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- ZSKGQVFRTSEPJT-UHFFFAOYSA-N pyrrole-2-carboxaldehyde Chemical compound O=CC1=CC=CN1 ZSKGQVFRTSEPJT-UHFFFAOYSA-N 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- GXUQMKBQDGPMKZ-AWEZNQCLSA-N (2r)-2-hydroxy-2-(3-phenoxyphenyl)acetonitrile Chemical compound N#C[C@H](O)C1=CC=CC(OC=2C=CC=CC=2)=C1 GXUQMKBQDGPMKZ-AWEZNQCLSA-N 0.000 description 1
- ZECLJEYAWRQVIB-MRVPVSSYSA-N (2s)-2-(2-chlorophenyl)-2-hydroxyacetonitrile Chemical compound N#C[C@@H](O)C1=CC=CC=C1Cl ZECLJEYAWRQVIB-MRVPVSSYSA-N 0.000 description 1
- GXUQMKBQDGPMKZ-CQSZACIVSA-N (2s)-2-hydroxy-2-(3-phenoxyphenyl)acetonitrile Chemical compound N#C[C@@H](O)C1=CC=CC(OC=2C=CC=CC=2)=C1 GXUQMKBQDGPMKZ-CQSZACIVSA-N 0.000 description 1
- KKGXJLAWLSJRGK-SECBINFHSA-N (2s)-2-hydroxy-2-(4-methylphenyl)acetonitrile Chemical compound CC1=CC=C([C@H](O)C#N)C=C1 KKGXJLAWLSJRGK-SECBINFHSA-N 0.000 description 1
- QAXOKMZVYDLXEW-QMMMGPOBSA-N (2s)-2-hydroxy-2-methylheptanenitrile Chemical compound CCCCC[C@](C)(O)C#N QAXOKMZVYDLXEW-QMMMGPOBSA-N 0.000 description 1
- NGLPDXCYIUHTNP-SECBINFHSA-N (2s)-2-hydroxy-2-phenylpropanenitrile Chemical compound N#C[C@](O)(C)C1=CC=CC=C1 NGLPDXCYIUHTNP-SECBINFHSA-N 0.000 description 1
- CUJUQPVHWIDESZ-JTQLQIEISA-N (2s)-2-hydroxy-4-phenylbutanenitrile Chemical compound N#C[C@@H](O)CCC1=CC=CC=C1 CUJUQPVHWIDESZ-JTQLQIEISA-N 0.000 description 1
- AKXFVHOXDAJSMM-YFKPBYRVSA-N (2s)-2-hydroxypent-3-enenitrile Chemical compound CC=C[C@H](O)C#N AKXFVHOXDAJSMM-YFKPBYRVSA-N 0.000 description 1
- IWYDHOAUDWTVEP-SSDOTTSWSA-N (R)-mandelic acid Chemical compound OC(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-N 0.000 description 1
- NNICRUQPODTGRU-MRVPVSSYSA-N (S)-mandelonitrile Chemical compound N#C[C@@H](O)C1=CC=CC=C1 NNICRUQPODTGRU-MRVPVSSYSA-N 0.000 description 1
- WAGPFYGOLZGETK-UHFFFAOYSA-N 1-(1h-indol-2-yl)propan-2-one Chemical compound C1=CC=C2NC(CC(=O)C)=CC2=C1 WAGPFYGOLZGETK-UHFFFAOYSA-N 0.000 description 1
- SQAINHDHICKHLX-UHFFFAOYSA-N 1-naphthaldehyde Chemical compound C1=CC=C2C(C=O)=CC=CC2=C1 SQAINHDHICKHLX-UHFFFAOYSA-N 0.000 description 1
- WAPNOHKVXSQRPX-UHFFFAOYSA-N 1-phenylethanol Chemical compound CC(O)C1=CC=CC=C1 WAPNOHKVXSQRPX-UHFFFAOYSA-N 0.000 description 1
- ICFGFAUMBISMLR-UHFFFAOYSA-N 1h-pyrazole-5-carbaldehyde Chemical compound O=CC=1C=CNN=1 ICFGFAUMBISMLR-UHFFFAOYSA-N 0.000 description 1
- RWOLDZZTBNYTMS-UHFFFAOYSA-N 2-(2-chlorophenyl)-2-hydroxyacetic acid Chemical compound OC(=O)C(O)C1=CC=CC=C1Cl RWOLDZZTBNYTMS-UHFFFAOYSA-N 0.000 description 1
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 1
- 239000001431 2-methylbenzaldehyde Substances 0.000 description 1
- JPHKMYXKNKLNDF-UHFFFAOYSA-N 3,4-difluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1F JPHKMYXKNKLNDF-UHFFFAOYSA-N 0.000 description 1
- AZVSIHIBYRHSLB-UHFFFAOYSA-N 3-furaldehyde Chemical compound O=CC=1C=COC=1 AZVSIHIBYRHSLB-UHFFFAOYSA-N 0.000 description 1
- MRLGCTNJRREZHZ-UHFFFAOYSA-N 3-phenoxybenzaldehyde Chemical compound O=CC1=CC=CC(OC=2C=CC=CC=2)=C1 MRLGCTNJRREZHZ-UHFFFAOYSA-N 0.000 description 1
- VRZJGENLTNRAIG-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]iminonaphthalen-1-one Chemical compound C1=CC(N(C)C)=CC=C1N=C1C2=CC=CC=C2C(=O)C=C1 VRZJGENLTNRAIG-UHFFFAOYSA-N 0.000 description 1
- JDICMOLUAHZVDS-UHFFFAOYSA-N 4-fluoro-3-phenoxybenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1OC1=CC=CC=C1 JDICMOLUAHZVDS-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical class ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 108010054278 Lac Repressors Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010033272 Nitrilase Proteins 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 150000008043 acidic salts Chemical class 0.000 description 1
- 108091006088 activator proteins Proteins 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- XPNGNIFUDRPBFJ-UHFFFAOYSA-N alpha-methylbenzylalcohol Natural products CC1=CC=CC=C1CO XPNGNIFUDRPBFJ-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- YMNKUHIVVMFOFO-UHFFFAOYSA-N anthracene-9-carbaldehyde Chemical compound C1=CC=C2C(C=O)=C(C=CC=C3)C3=CC2=C1 YMNKUHIVVMFOFO-UHFFFAOYSA-N 0.000 description 1
- FRHBOQMZUOWXQL-UHFFFAOYSA-K azane;2-hydroxypropane-1,2,3-tricarboxylate;iron(3+) Chemical compound N.[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-K 0.000 description 1
- 150000003935 benzaldehydes Chemical class 0.000 description 1
- IZALUMVGBVKPJD-UHFFFAOYSA-N benzene-1,3-dicarbaldehyde Chemical compound O=CC1=CC=CC(C=O)=C1 IZALUMVGBVKPJD-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 150000003997 cyclic ketones Chemical class 0.000 description 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical group [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- XEYBHCRIKKKOSS-UHFFFAOYSA-N disodium;azanylidyneoxidanium;iron(2+);pentacyanide Chemical compound [Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].[O+]#N XEYBHCRIKKKOSS-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- CNUDBTRUORMMPA-UHFFFAOYSA-N formylthiophene Chemical compound O=CC1=CC=CS1 CNUDBTRUORMMPA-UHFFFAOYSA-N 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002634 lipophilic molecules Chemical class 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 235000019263 trisodium citrate Nutrition 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
Definitions
- Optically active ⁇ -hydroxycarboxylic acids are used, for example, as additives in animal feed or in the production of active pharmaceutical ingredients, vitamins and liquid crystals.
- optically active ⁇ -hydroxycarboxylic acids can also be described, for example, by Effenberger et al., Angew. Chem. 95 (1983) No. 1, page 50, advantageously convert it into N-substituted optically active ⁇ -amino acids which are otherwise very difficult to produce.
- Chiral ⁇ -hydroxycarboxylic acids are now chemically, fermentatively or enzymatically accessible.
- Racemic cyanohydrins can be hydrolyzed to the desired chiral ⁇ -hydroxycarboxylic acids with the addition of suitable microorganisms.
- optically active cyanohydrins can be hydrolyzed with concentrated hydrochloric acid without racemization to give the corresponding chiral ⁇ -hydroxycarboxylic acids.
- the optical purity of the chiral ⁇ -hydroxycarboxylic acids thus produced corresponds to the optical purity of the chiral cyanohydrin used, even if it is obtained in situ by enzyme-catalyzed addition of a cyanide group to a corresponding aldehyde or a ketone and is further processed without isolation or purification.
- the present invention accordingly relates to a process for the preparation of chiral ⁇ -hydroxycarboxylic acids, which is characterized in that (R) - or (S) -cyanohydrins in the presence of Rhodococcus erythropolis NCIMB 11540 by enzymatic hydrolysis into the corresponding (R) - or (S) - ⁇ - Hydroxycarboxylic acids are transferred.
- (R) ⁇ and (SJ-cyanohydrins are converted into (R) - and SJ- ⁇ -hydroxycarboxylic acids with an optical purity of up to> 99% ee.
- the starting compounds used are (R) - and (S) - cyanohydrins, which are produced by enzymatic or chemically catalyzed addition of a cyanide group to the corresponding aldehydes or ketones.
- aldehydes are aliphatic, aromatic or heteroaromatic aldehydes.
- Aliphatic aldehydes are to be understood as meaning saturated or unsaturated aliphatic, straight-chain, branched or cyclic aldehydes.
- Preferred aliphatic aldehydes are straight-chain aldehydes having in particular 2 to 18 carbon atoms, particularly preferably 2 to 12, which are saturated or mono- or polyunsaturated.
- the aldehyde can have both CC double bonds and CC triple bonds.
- the aldehyde can be unsubstituted or one or more times by groups which are inert under the reaction conditions, for example by optionally substituted aryl or heteroaryl groups, such as phenyl or indolyl groups, by C 1 -C 6 -alkyl, optionally substituted cycloalkyl groups which have one or more heteroatoms from the group O, S, P, or N can be substituted, halogen, ether, alcohol, acyl, carboxylic acid, carboxylic acid ester, nitro or azido groups.
- groups which are inert under the reaction conditions for example by optionally substituted aryl or heteroaryl groups, such as phenyl or indolyl groups, by C 1 -C 6 -alkyl, optionally substituted cycloalkyl groups which have one or more heteroatoms from the group O, S, P, or N can be substituted, halogen, ether, alcohol, acyl, carboxylic acid, carboxylic acid
- aromatic or heteroaromatic aldehydes are benzaldehyde or variously substituted benzaldehydes such as 2-chlorobenzaldehyde, 3,4- Difluorobenzaldehyde, 4-methylbenzaldehyde, 3-phenoxybenzaldehyde, 4-fluor-3-phenoxybenzaldehyde, further furfural, anthracene-9-carbaldehyde, furan-3-carbaldehyde, indole-3-carbaldehyde, naphthalene-1-carbaldehyde, phthalaldehyde, pyrazole -3-carbaldehyde, pyrrole-2-carbaldehyde, thiophene-2-carbaldehyde, isophthalaldehyde or pyridine aldehydes, etc.
- benzaldehyde or variously substituted benzaldehydes such as 2-chlorobenzaldehyde, 3,4
- ketones are aliphatic, aromatic or heteroaromatic ketones in which the carbonyl carbon atom is unequally substituted.
- Aliphatic ketones are straight-chain, branched or cyclic ketones.
- the ketones can be saturated or mono- or polyunsaturated. You can unsubstituted or one or more times by groups inert under the reaction conditions, for example by optionally substituted aryl or heteroaryl groups such as phenyl or indolyl groups, by halogen, ether, alcohol, acyl, carboxylic acid, carboxylic acid ester, Nitro or azido groups can be substituted.
- aromatic or heteroaromatic ketones are acetophenone, indolylacetone, etc.
- R1 X R2 z in the R1 and R2 are independently H, an optionally mono- or polysubstituted with inert under the reaction conditions substituent substituted C- ⁇ -C 6 - alkyl or alkenyl radical or an optionally mono- or polysubstituted with inert under the reaction conditions substituent substituted phenyl radical, with the proviso that R1 and R2 are not both H.
- Preferred substituents which are inert under the reaction conditions are, for example, halogens, such as fluorine, bromine and chlorine, C 1 -C 6 -alkyl or alkoxy, ethers, esters, acetals or optionally substituted phenyl and phenyloxy.
- (R) - or (S) - cyanohydrins such as (R) - or (S) -2-hydroxy-4-phenyl-butyronitrile, (R) - or (S) -2 - Chloromandelonitrile, (R) - or (S) -mandelonitrile, (R) - or (S) -4-methylmandelonitrile, (R) - or (S) -3-phenoxymandelonitrile, (R) - or (S) -2 -Hydroxy-2-methyl-heptanenitrile, (R) - or (S) -2-hydroxy-2-phenyl-propionitrile, (R) - or (S) -2-hydroxy-3-pentenenitrile, (R) - or (S) -l-hydroxy-cyclohexanenitrile, (R) - or (S) -acetophenonecyna
- the enzymatic hydrolysis takes place in the presence of Rhodococcus erythropolis NCIMB 11540.
- Rhodococcus erythropolis NCIMB 11540 has unexpectedly found a microorganism which is distinguished by the fact that it has a nitrile hydrate / amidase enzyme system which can hydrolyze the nitrile function of such polar nitriles as the cyanohydrins mentioned above.
- the chiral cyanohydrins are hydrolyzed in the first step by the nitrile hydratase into the corresponding chiral hydroxyamide, which is then converted in a second hydrolysis step by the amidase into the corresponding chiral ⁇ -hydroxycarboxylic acid.
- microorganism can be used in the method according to the invention in any form, for example in the form of ground cells, crude or purified enzymes, recombinant enzymes, immobilized cells or enzymes, lyophilized cells or "resting cells".
- Recombinant enzymes, resting cells or lyophilized cells are preferably used, particularly preferably recombinant enzymes or resting cells.
- a suitable microorganism such as E. coli, Pichia pastoris, Saccharomyces, Asperagillus, K. Lactis, etc.
- the corresponding genes are introduced with the aid of plasmid constructs into suitable host cells, for example in E. coli, Pichia pastoris, Saccharomyces, Asperagillus, K. Lactis host cells.
- both the nitrile hydratase and the amidase can be overexpressed in active form.
- amidase much higher activity levels can be achieved than with corresponding fermentation of the Rhodococcus cells.
- aqueous medium such as water or a buffer solution.
- aqueous medium such as water or a buffer solution.
- buffer solutions are, for example, phosphate buffers such as K / Na phosphate buffers, PBS buffers, butyrate buffers, citrate solutions, etc.
- the pH of the buffer solution used should be in a range from pH 4.5 to pH 11, preferably from 5.5 to 8.5.
- the corresponding chiral cyanohydrin is then added to the suspension thus obtained. Since the chiral cyanohydrins are lipophilic compounds with limited water solubility, the use of a solubilizer as a cosolvent is necessary in order to dissolve the cyanohydrins in an aqueous medium.
- Suitable solubilizers are, for example, organic solvents, surfactants, phase transfer catalysts, etc.
- Organic solvents which are suitable as cosolvents for the process according to the invention are those which firstly sufficiently dissolve the substrate and secondly impair the enzyme activity as little as possible.
- Examples include dimethyl sulfoxide (DMSO), dimethylformamide (DMF), Ci-C ⁇ alcohols, such as methanol, ethanol, i-propanol, 1-butanol, 2-butanol, t-butanol or 1-pentanol, toluene or t.- Butyl methyl ether (TBME) or mixtures thereof.
- DMSO, DMF, ethanol, i-propanol or mixtures thereof, and particularly preferably DMSO and DMF are preferably used as cosolvents.
- the proportion of cosolvents should be between 0.5 and 20% by volume, based on the total volume of the reaction solution.
- the cosolvent fraction is preferably between 1 and 15 vol% and particularly preferably between 2 and 10 vol%.
- the substrate concentration in the reaction solution in the process according to the invention should be in a range from 1 g / l to 10Og / l (based on the total volume of the reaction solution), the acceptance of a sufficiently high substrate concentration being the basic prerequisite for the use of the enzymatic hydrolysis according to the invention in the preparative Scale is.
- Substrate concentrations of up to 50 g / l are preferred, particularly preferably up to 25 g / l.
- the possible convertible substrate concentration depends on the amount of enzyme used.
- the first hydrolysis step has to be carried out very quickly in order to avoid the disintegration of the cyanohydrin and the resulting racemization, so that relatively high cell densities are required.
- the amount of cells or enzyme depends on the activity of the microorganism in the form used, as well as on the substrate concentration and the cosolvent.
- the pH of the reaction mixture should be between 4.5 and 11, preferably between 5.5 and 8.
- a suitable acid or acidic salts such as phosphoric acid, boric acid, citric acid, etc., can be added to the reaction mixture to adjust the pH. be added.
- the enzymatic hydrolysis according to the invention is carried out at a temperature of 10 to 60 ° C., preferably at 15 to 50 ° C. and particularly preferably at 20 to 45 ° C.
- hydrolysis to the desired chiral ⁇ -hydroxycarboxylic acids After hydrolysis to the desired chiral ⁇ -hydroxycarboxylic acids, they are isolated from the reaction mixture using a known technique, such as centrifuging the cells, extracting the product after acidification with HCl (e.g. pH 2) and, if appropriate, further purifying it by activated carbon filtration and recrystallization.
- HCl e.g. pH 2
- Rhodococcus erythropolis NCIMB 11540 thus converts polar nitriles, such as chiral cyanohydrins, into the corresponding chiral ⁇ -hydroxycarboxylic acids in a simple and efficient manner under mild conditions, with no racemization occurring.
- polar nitriles such as chiral cyanohydrins
- the desired ⁇ -hydroxycarboxylic acids are obtained in high optical purity of up to over 99% and in high yields of up to over 98%.
- a complex standard medium (Medium A, see Table 1) was used to produce the Rhodococcus erythropolis NCIMB 11540 biomass.
- the stock was kept on agar plates with medium A (solidification with 15 g / l agar). The plates were sealed by wrapping parafilm on the side and stored in the refrigerator at 4 ° C.
- Variant I (without preculture): About half of the biomass of an agar plate was suspended in 5 ml of sterile, physiological saline. One cell suspension each was added to 250 ml of culture medium.
- the cells were harvested by centrifugation at approx. 3000rpm for 30min at 0-4 ° C.
- the cells were washed once with K / Na phosphate buffer (50mM, pH 6.5).
- the cells were then resuspended in fresh buffer and either lyophilized after shock freezing (reactions with lyophilized cells, example 2), or this cell suspension (about 6-8% of the culture volume) was used directly for the biocatalytic reactions (reactions with resting cells, example 3).
- Example 2 Reactions with lyophilized cells on an analytical scale
- Example 3 Enzymatic hydrolysis using resting cells and lyophilized cells
- the cells were resuspended in 1.8 ml K / Na-PO 4 buffer (pH 6.5, 50 mM) (lyophilized cells were shaken for 1 hour for rehydration).
- the reaction was started by adding 200 ⁇ l of a 200mM substrate solution in DMSO (substrate concentration approx. 20mM) and carried out at 30 ° C. and 130rpm in a shaker. After 30 min, 60 min and 17 h, 200 ⁇ l were removed and 200 ⁇ l of 1N HCl were added. After centrifugation (5 min, 13,000 rpm) and dilution, the conversions were determined by means of HPLC. Only the substrate and the two products were taken into account.
- the conversion of the hydroxyamide (HA) relates to the amount of hydroxy acid that was formed from the hydroxyamide present.
- reaction was carried out on an analytical scale (reaction volume 1 ml) with 3 substrate concentrations (2.2g / l, 6.6g / l, 13.2g / l).
- the biocatalyst was prepared according to Example 1, Variant II, 21 fermentation medium, harvest after 20 hours (ODs 46 6.1).
- the cells from 8 x 10 ml fermentation solution were centrifuged off in culture tubes.
- the cell mass obtained was washed once with 2 ml of K Na phosphate buffer (pH 6.5, 50 mM).
- the contents of 2 tubes were lyophilized to determine the dry weight.
- Substrate solution 11mg (R) -2-chloromandelonitrile in 250 ⁇ l DMSO (approx. 260mM) substrate concentration in the batch: 2.2g / l (13.1mM) b.
- Substrate concentration in the batch Substrate concentration: 6.6g / l (39.4mM)
- Substrate concentration in the batch 13.2g / l (78.8mM)
- reaction was carried out with 2 different substrate concentrations (10 g / l, 20 g / l) on a 5 ml scale.
- the biocatalyst was prepared according to Example 1, Variant II, 21 fermentation medium, harvest after 19 hours (OD 546 8.4).
- the cells were resuspended in approx. 140 ml buffer (Resting cells, OD 5 6 52). 4.75 ml each of this cell suspension was used for the enzymatic reactions.
- Two different concentrations of (R) -2-chloromandelonitrile were investigated in parallel.
- the reaction was started by adding 250 ⁇ l of substrate solution and carried out in culture tubes in a shaking cabinet at 30 ° C. and 130 rpm. To check the turnover, 200 ⁇ l were taken in each case and 200 ⁇ l of 1 N HCl were added. After centrifugation (5 min, 13,000 rpm) and dilution, the conversions were determined using HPLC.
- the biocatalyst was prepared according to Example 1, Variant II, 2.75I fermentation medium, harvested after 20 hours.
- the cells were resuspended in approx. 200 ml buffer (Resting cells, OD 5 6 44). 4.85 ml each of this cell suspension were used for the enzymatic reactions.
- the cells were suspended in 100 ml K / Na phosphate buffer (pH 6.5, 50mM). This cell suspension (OD 60) was used for the enzymatic reactions.
- the reactions of (R) -2-chloromandelonitrile, dissolved in DMSO or EtOH, were carried out in 100 ml Schlifferienmeyer flasks at 150rpm and 30 ° C.
- 200 ⁇ l of sample were mixed with 200 ⁇ l of 1N HCl, centrifuged (5 min, 13,000 rpm) and diluted before the measurement. After complete conversion, the ee of the product was determined.
- the substrate concentration was 10 g / l (R) -2-chloromandelonitrile.
- the reaction was carried out on a 5 ml scale.
- Example 7 Reactions of cyanohydrins from aldehydes with Rhodococcus erythropolis NCIMB 11540 on a semi-preparative scale
- the biocatalyst was produced in accordance with Example 1, variant II. 31 fermentation medium, harvest after 20 hours (ODs 46 5.9). The cells were resuspended to about 180 ml in buffer (Resting cells, OD54 6 80).
- experiment 7.2 some reaction parameters were varied.
- the standard conditions were 10 g / l substrate and DMSO as cosolvent (here 2.5%).
- a second batch was carried out with 15 g / l substrate, another with 10 g / l substrate and DMF as cosolvent.
- the biocatalyst was produced in accordance with Example 1, variant II. 31 fermentation medium, harvest after 20 hours (ODs 4 6 6.8). The cells were resuspended to about 190 ml buffer (Resting cells, OD54 6 69). Three implementations were carried out.
- Batch A 0.3 g (R) -2-chloromandelonitrile (ee> 99%), dissolved in 750 ⁇ l DMSO, 30 ml of this cell suspension were added.
- the hydrolysis was carried out at 40 ° C. and 150 rpm in the shaker. After 30 minutes the cyanohydrin was completely hydrolyzed, after 5 hours the conversion to (R) -2-chloromandelic acid was complete. Crude yield: 0.31g (93%) Product ee:> 99%
- Batch B 0.3 g (R) -2-chloromandelonitrile (ee> 99%), dissolved in 750 ⁇ l DMF, 30 ml of this cell suspension were added.
- batch A 10g / l batches with different substrate concentrations (batch A 10g / l, batch B 15g / l) were carried out. Both implementations were almost equally quick and were complete after 2 hours.
- the biocatalyst was produced in accordance with Example 1, variant II. 31 fermentation medium, harvest after 20 hours (OD 546 1.2). The cells were resuspended in approximately 180 ml of buffer (Resting cells, OD 546 70). Two implementations were carried out.
- the biocatalyst was produced according to Example 1, variant II, 2.5I fermentation medium, harvest after 20 hours (OD 546 6.9).
- the cells were resuspended in approx. 160 ml buffer (Resting cells, OD 546 63).
- the biocatalyst was produced according to Example 1, Variant II, 21 fermentation medium, harvest after 20 hours (OD 546 8.4).
- the cells were resuspended in approx. 120 ml buffer (Resting cells, OD 546 74).
- the reaction was carried out after freezing the biocatalyst overnight.
- the hydrolysis was carried out at 40 ° C. and 150 rpm in the shaker. After 15 minutes the cyanohydrin was completely hydrolyzed, after 5 hours the conversion to (R) -mandelic acid was complete. Crude yield: 1.16g (100%) Product ee: 93%
- Example 8 Reactions of cyanohydrins from ketones with Rhodococcus erythropolis NCIMB 11540 on a semi-preparative scale
- the biomass was centrifuged off at 4 ° C. and 6000 rpm for 20 min and once with H 2 0 dist. washed. After acidifying the supernatant with 1 N HCl to pH 2, extraction was carried out 3-4 times with TBME.
- the biocatalyst is produced according to Example 1, variant II, 2L fermentation medium, harvest after 20 hours.
- the cells were resuspended in approx. 60 ml buffer (Resting cells, OD 546 60).
- the pMS470 plasmid system was used to express the nitrile hydratase and to express the amidase.
- this plasmid has an inducible tac promoter which allows controlled overexpression of the cloned open reading frames.
- the plasmid map can be seen in Figure 1.
- the plasmid is called pMS470Nhse7.3.
- ⁇ and ⁇ subunit In addition to the two gene segments of nitrile hydratase ( ⁇ and ⁇ subunit), it also contains a third open reading frame which codes for an activator protein.
- the fermentation of the two enzymes was basically carried out according to the general protocol, worked out for the overexpression of enzymes in the pMS470 system.
- the E. coli B BL21 cells transformed with pMS470Nhase7.3 (or pMSNhasetactac7.3) were separated on LB ampicillin plates and an ONC of 100 ml LB ampicillin medium was inoculated with a single colony.
- pMS470Nhase7.3 or pMSNhasetactac7.3
- the growth temperature was controlled at 25 ° C., since at higher temperatures only insoluble inclusion bodies are formed.
- the cultures were induced by adding IPTG to a concentration of 0.1 mM.
- the media were supplemented with 0.1 mM ammonium iron (III) citrate.
- the cultures were harvested (centrifugation at approx. 3000 * g for 15 min) and washed once with approx. 100 ml PBS buffer.
- the cell pellet was then resuspended in PBS buffer (approx. 5ml total volume) and disrupted with an ultrasound probe (BRANSON Sonifier 250, 60% power setting, constant sonication; 5 times 30s with 1 minute break for cooling) (visual check of completeness under the Microscope).
- the crude lysates thus obtained had a typical activity of approx. 100-250 U / ml (approx.
- the E. coli B BL21 cells transformed with pMS470-33 / 3/1/11 were isolated on LB-ampicillin plates and an ONC of 100 ml LB-ampicillin medium was inoculated with a single colony.
- a main culture consisting of 250 ml SOC ampicillin medium in a 1000 ml baffle flask was inoculated to an OD 6 oo of 0.01 to 0.03 (Beckmann photometer).
- the growth temperature was adjusted to 30 ° C because the fermentation at 37 ° C only leads to the formation of insoluble and inactive protein.
- the cultures were induced by adding IPTG to a concentration of 0.3mM.
- the pellet obtained was resuspended to a total volume of approx. 5 ml in the wash buffer and disrupted to completion with an ultrasound probe (BRANSON Sonifier 250, 60% power setting, constant sonication; 5 times 30 s with 1 min break for cooling) with constant cooling (visual check of completeness Under the microscope).
- the crude lysates obtained in this way were frozen at -20 ° C for preservation.
- the lysates had an activity of approx. 75 U / ml, determined with acetamide (40mM) as substrate in PBS buffer at 37 ° C
- Solution A 10% (w / v) phenol in ethanol (95%)
- Solution B 0.5% (w / v) nitroprusside sodium in ddH 2 0
- Solution C 100g tri-sodium citrate and 5g of sodium hydroxide in 550 ml water
- Solution D 600ml commercial sodium hypochlorite solution diluted to 1000ml
- Ammonium standards 0, 80, 120, 200, 280, 400 ⁇ g / l ammonium sulfate in water
- Rhodococcus erythropolis NCIMB 11540 nitrile hydratase was used as the crude lysate of E. coli clone 7.3 (prepared according to Example 9).
- the activity of the nitrile hydratase was determined on the basis of the rate of formation of the hydroxyamide (slope in the initial region).
- 2-Hydroxy-4-phenyl-butyronitrile was used as the standard substrate (100% activity).
- the activity in the hydrolysis of the other substrates was compared with the activity on 2-hydroxy-4-phenyl-butyronitrile (Table 5).
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0028503A AT412092B (en) | 2003-02-27 | 2003-02-27 | METHOD FOR PRODUCING CHIRAL ALPHA HYDROXYCARBOXYLIC ACIDS BY ENZYMATIC HYDROLYSIS OF CHIRAL CYANHYDRINES |
PCT/EP2004/000859 WO2004076385A2 (en) | 2003-02-27 | 2004-01-30 | METHOD FOR PRODUCING CHIRAL α HYDROXYCARBOXYLIC CRYSTALLINE ACIDS |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1625104A2 true EP1625104A2 (en) | 2006-02-15 |
Family
ID=31192762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04706636A Withdrawn EP1625104A2 (en) | 2003-02-27 | 2004-01-30 | METHOD FOR PRODUCING CHIRAL alpha HYDROXYCARBOXYLIC CRYSTALLINE ACIDS |
Country Status (6)
Country | Link |
---|---|
US (3) | US7390647B2 (en) |
EP (1) | EP1625104A2 (en) |
JP (1) | JP2006525795A (en) |
AT (1) | AT412092B (en) |
CA (1) | CA2517301A1 (en) |
WO (1) | WO2004076385A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT412092B (en) * | 2003-02-27 | 2004-09-27 | Dsm Fine Chem Austria Gmbh | METHOD FOR PRODUCING CHIRAL ALPHA HYDROXYCARBOXYLIC ACIDS BY ENZYMATIC HYDROLYSIS OF CHIRAL CYANHYDRINES |
JP5001523B2 (en) * | 2005-04-27 | 2012-08-15 | 三菱レイヨン株式会社 | Method for producing optically active cyanohydrin and method for producing optically active α-hydroxycarboxylic acid |
DE102006010254B4 (en) * | 2006-03-02 | 2008-09-04 | Evonik Degussa Gmbh | Enzyme-catalyzed hydrolysis of optically active 2-hydroxy-4- (methylthio) butyric acid nitrile |
JP2012105671A (en) * | 2012-02-28 | 2012-06-07 | Mitsubishi Rayon Co Ltd | METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRIN AND METHOD FOR PRODUCING OPTICALLY ACTIVE α-HYDROXY CARBOXYLIC ACID |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8403093A (en) * | 1984-10-11 | 1986-05-01 | Stamicarbon | PROCESS FOR THE ENZYMATIC HYDROLYSIS OF D-ALFA-AMINO ACID AMIDS. |
US5593871A (en) * | 1990-09-20 | 1997-01-14 | E. I. Du Pont De Nemours And Company | Process for the preparation of enantiometric 2-alkanoic acid amides from nitriles |
JP2676568B2 (en) * | 1991-06-26 | 1997-11-17 | 日東化学工業株式会社 | Method for producing R (-)-mandelic acid and its derivatives |
JP2720140B2 (en) * | 1993-02-03 | 1998-02-25 | 日東化学工業株式会社 | Method for producing optically active α-hydroxycarboxylic acid having phenyl group |
JP3224654B2 (en) * | 1993-10-27 | 2001-11-05 | 三菱レイヨン株式会社 | Process for producing optically active α-hydroxycarboxylic acid and α-hydroxyamide |
JP3119468B2 (en) * | 1994-11-09 | 2000-12-18 | 三菱レイヨン株式会社 | Method for producing optically active α-hydroxy acid or α-hydroxyamide |
AT404837B (en) * | 1995-07-12 | 1999-03-25 | Chemie Linz Gmbh | (S) -HYDROXYNITRILLYASE FROM HEVEA BRAZIL SIS |
JPH11513255A (en) * | 1995-10-06 | 1999-11-16 | イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー | Nucleic acid fragments encoding stereospecific nitrile hydratase and amidase enzymes, and recombinant microorganisms expressing those enzymes useful for the production of chiral amides and acids |
US5756306A (en) * | 1995-11-10 | 1998-05-26 | Nitto Chemical Industry Co., Ltd. | Process for producing a-hydroxy acid or a-hydroxyamide by microorganism |
DE19848129A1 (en) | 1998-10-19 | 2000-04-20 | Basf Ag | New nucleic acid sequence encoding Alcaligenes faecalis nitrilase polypeptide useful for converting racemic nitriles to chiral carboxylic acids |
US6562603B2 (en) * | 2000-08-04 | 2003-05-13 | E. I. Du Pont De Nemours And Company | 3-hydroxycarboxylic acid production and use in branched polymers |
ATE435278T1 (en) * | 2003-02-27 | 2009-07-15 | Basf Se | MODIFIED NITRILASES AND THEIR USE IN PROCESS FOR PRODUCING CARBOXYLIC ACIDS |
AT412092B (en) | 2003-02-27 | 2004-09-27 | Dsm Fine Chem Austria Gmbh | METHOD FOR PRODUCING CHIRAL ALPHA HYDROXYCARBOXYLIC ACIDS BY ENZYMATIC HYDROLYSIS OF CHIRAL CYANHYDRINES |
DE10347888A1 (en) * | 2003-10-10 | 2005-06-30 | Degussa Ag | Process for the preparation of enantiomerically enriched alpha-hydroxycarboxylic acids or amides |
UA82292C2 (en) * | 2004-04-14 | 2008-03-25 | Пфайзер Продактс Инк. | A method for stereoselective byconversion of aliphatic dinitriles into cyanocarboxylic acids (variants) |
US7148051B2 (en) * | 2004-08-16 | 2006-12-12 | E. I. Du Pont De Nemours And Company | Production of 3-hydroxycarboxylic acid using nitrilase |
-
2003
- 2003-02-27 AT AT0028503A patent/AT412092B/en not_active IP Right Cessation
-
2004
- 2004-01-30 JP JP2006501668A patent/JP2006525795A/en active Pending
- 2004-01-30 US US10/544,103 patent/US7390647B2/en not_active Expired - Fee Related
- 2004-01-30 WO PCT/EP2004/000859 patent/WO2004076385A2/en active Application Filing
- 2004-01-30 EP EP04706636A patent/EP1625104A2/en not_active Withdrawn
- 2004-01-30 CA CA002517301A patent/CA2517301A1/en not_active Abandoned
-
2005
- 2005-09-09 US US11/222,020 patent/US7514245B2/en not_active Expired - Fee Related
-
2008
- 2008-03-18 US US12/076,388 patent/US20080206827A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO2004076385A2 * |
Also Published As
Publication number | Publication date |
---|---|
WO2004076385A3 (en) | 2006-04-06 |
US20060099696A1 (en) | 2006-05-11 |
ATA2852003A (en) | 2004-02-15 |
US7514245B2 (en) | 2009-04-07 |
US7390647B2 (en) | 2008-06-24 |
JP2006525795A (en) | 2006-11-16 |
US20080206827A1 (en) | 2008-08-28 |
WO2004076385A2 (en) | 2004-09-10 |
CA2517301A1 (en) | 2004-09-10 |
AT412092B (en) | 2004-09-27 |
US20060199256A1 (en) | 2006-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0326063B1 (en) | Process for the preparation of optically active cyanhydrins | |
EP0012278B1 (en) | Preparation of n-substituted derivatives of 1-deoxy-nojirimycine | |
DE69420754T2 (en) | Process for the preparation of optically active alpha-hydroxycarboxylic acids containing phenyl group | |
EP4045500A1 (en) | Process for producing acyloxymethyl esters of (4s)-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxylic acid | |
DE69219530T2 (en) | Process for the preparation of R (-) - mandelic acid and its derivative | |
DE69421425T2 (en) | Process for the preparation of optically active alpha-hydroxycarboxylic acids containing phenyl group | |
RU2004122912A (en) | METHOD FOR PRODUCING CO-ENZYME Q10 | |
DD221905B1 (en) | PROCESS FOR THE PREPARATION OF L (-) - CARNITINE AND ITS DERIVATIVES | |
EP0326482A1 (en) | Process for the preparation of optically active 2-aryl-alkanoic acids | |
EP1625104A2 (en) | METHOD FOR PRODUCING CHIRAL alpha HYDROXYCARBOXYLIC CRYSTALLINE ACIDS | |
AT406959B (en) | ENANTIOSELECTIVE METHOD FOR PRODUCING (S) -CYANHYDRINES | |
DE60012802T2 (en) | Process for the preparation of optically active cyanohydrins | |
DE69737696T2 (en) | PROCESS FOR THE PREPARATION OF ALPHA HYDROXYLIC ACIDS WITH THE HELP OF MICROORGANISM AND NEW MICROORGANISM. | |
EP1688501B1 (en) | Process for the preparation of manool and manool ketone | |
AT411065B (en) | METHOD FOR PRODUCING HETEROCYCLIC (R) - AND (S) -CYANHYDRINES | |
DE69905218T2 (en) | Process for the preparation of L-allysine acetal | |
DE69935254T2 (en) | PROCESS FOR PREPARING PYRROL-2-CARBOXYLIC ACID | |
CA2528388A1 (en) | Biocatalytic preparation of 1-cyanocyclohexaneacetic acid | |
JP2002281993A (en) | Method for producing shikimic acid | |
DE102006010254B4 (en) | Enzyme-catalyzed hydrolysis of optically active 2-hydroxy-4- (methylthio) butyric acid nitrile | |
FR2631975A1 (en) | OPTICALLY ACTIVE ALKANOIC ARYLOXY-2 OR ARYLTHIO-2 ACID PREPARATION PROCESS | |
EP0747486A1 (en) | Microbiological method for the synthesis of heteroaromatic caboxylic acids using microorganisms of the genus Alcaligenes | |
JP4061862B2 (en) | Optical resolution of chlorohydrin by microorganisms. | |
JP2005170794A (en) | Optically active 2-alkyl-d-cysteineamide or its salt and method for producing these compounds | |
WO1998027222A1 (en) | Method for production of d-proline derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
17P | Request for examination filed |
Effective date: 20050810 |
|
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12P 7/42 20060101AFI20060510BHEP |
|
17Q | First examination report despatched |
Effective date: 20070531 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20091204 |